Juan Pablo Merea Otermin, COO & Co-Founder at Cromodata, shared a post on LinkedIn:
“At American Society of Clinical Oncology (ASCO), I sat across from oncologists from Guatemala, Costa Rica, Brazil and Colombia.
Different countries, different systems all carrying that same commitment to advancing cancer care across the region.
I connected with renowned institutions close to home such as Hospital Italiano de Buenos Aires and Fundacion Santa Fe de Bogota
But also with H. Lee Moffitt Cancer Center and Research Institute, Inc. treating thousands of Hispanic patients in the United States.
From North to South America, the clinicians and institutions I met share the same urgency to improve outcomes for their patients.
But when it comes to the data powering the predictive models and the precision oncology platforms, the clinical data of their patients was largely absent.
In other words, the clinical reality of Latin America was at ASCO. Its data, mostly, was not.
This is the gap that data purity addresses. The problem isn’t that Latin America doesn’t generate clinical data.
We generate it every day, in millions of studies, across thousands of institutions.
At Cromodata, we’ve built the largest real-world data hub in Latin America: a platform that ensures datasets are anonymized, research-ready, and ready to connect with global research.
If you were at ASCO and this topic resonates, I’d love to connect and help spread awareness.
Thank you Maria Gabriela Pittis and Keila Barral Masri for being there with me.”